Durham, NC, United States of America

Zachary C Hartman

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Zachary C Hartman

Introduction

Zachary C Hartman is a prominent inventor based in Durham, NC (US), known for his significant contributions to the field of cancer therapeutics. With a total of 8 patents, Hartman has focused on developing innovative vaccines aimed at combating cancer and precancerous conditions.

Latest Patents

Hartman's latest patents include groundbreaking work on vaccines against an oncogenic isoform of HER2 (ErbB2). These methods aim to reduce the likelihood of cancer or precancer developing resistance to therapeutic agents. The vaccines utilize a polynucleotide encoding a polypeptide correlated with resistance development, which can be administered alongside cancer therapeutics or immunomodulatory agents. Additionally, he has developed compositions and methods for delivering cancer vaccines, emphasizing combination treatments that enhance the efficacy of immunomodulatory agents.

Career Highlights

Zachary C Hartman is affiliated with Duke University, where he continues to advance research in cancer treatment. His work has garnered attention for its potential to improve patient outcomes through innovative vaccine strategies.

Collaborations

Hartman collaborates with esteemed colleagues, including Herbert K Lyerly and Takuya Osada, to further enhance the impact of his research in the field of oncology.

Conclusion

Zachary C Hartman's contributions to cancer treatment through innovative vaccine development highlight his role as a leading inventor in the medical field. His work promises to pave the way for more effective cancer therapies in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…